BR0207436A - Lactic acid bacteria to prevent infection with intimin expressing pathogens - Google Patents

Lactic acid bacteria to prevent infection with intimin expressing pathogens

Info

Publication number
BR0207436A
BR0207436A BR0207436-2A BR0207436A BR0207436A BR 0207436 A BR0207436 A BR 0207436A BR 0207436 A BR0207436 A BR 0207436A BR 0207436 A BR0207436 A BR 0207436A
Authority
BR
Brazil
Prior art keywords
lactic acid
acid bacteria
prevent infection
intimin
pathogens
Prior art date
Application number
BR0207436-2A
Other languages
Portuguese (pt)
Inventor
Jacque-Edouard Germond
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0207436A publication Critical patent/BR0207436A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"BACTéRIAS DE áCIDO LáTICO PARA PREVENçãO DE INFECçãO COM PATóGENOS EXPRESSANDO INTIMINA". A presente invenção pertence a bactérias de ácido lático, mostrando uma parte da proteína intimina sobre sua superfície. Em particular, a presente invenção pertence ao uso de tais bactérias de ácido lático como um meio para vacinação de indivíduos contra Escherichia coli entero-hemorrágica (EHEC) e/ou Escherichia coli enteropatogênica (EPEC)."Lactic Acid Bacteria to Prevent Infection with Pathogens Expressing INTIMINE". The present invention belongs to lactic acid bacteria, showing a part of the intimin protein on its surface. In particular, the present invention pertains to the use of such lactic acid bacteria as a means for vaccinating individuals against enterohemorrhagic Escherichia coli (EHEC) and / or enteropathogenic Escherichia coli (EPEC).

BR0207436-2A 2001-12-21 2002-12-18 Lactic acid bacteria to prevent infection with intimin expressing pathogens BR0207436A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01130719 2001-12-21
PCT/EP2002/014830 WO2003053461A2 (en) 2001-12-21 2002-12-18 Lactic acid bacteria for preventing infection with intimin expressing pathogens

Publications (1)

Publication Number Publication Date
BR0207436A true BR0207436A (en) 2004-06-01

Family

ID=8179661

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0207436-2A BR0207436A (en) 2001-12-21 2002-12-18 Lactic acid bacteria to prevent infection with intimin expressing pathogens

Country Status (5)

Country Link
AR (1) AR037952A1 (en)
AU (1) AU2002363899A1 (en)
BR (1) BR0207436A (en)
TW (1) TW200305434A (en)
WO (1) WO2003053461A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000510332A (en) * 1996-04-19 2000-08-15 ヘンリー エム．ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン Methods of stimulating an immune response by administering a host organism expressing intimin alone or as a fusion protein with one or more other antigens
EP1057892A1 (en) * 1999-06-02 2000-12-06 Centrum voor Onderzoek in Diergeneeskunde en Agrochemie Attenuated mutant enteropathogenic E. coli (EPEC) strains, process for their production and their use

Also Published As

Publication number Publication date
AU2002363899A1 (en) 2003-07-09
WO2003053461A3 (en) 2003-11-20
WO2003053461A2 (en) 2003-07-03
AR037952A1 (en) 2004-12-22
TW200305434A (en) 2003-11-01

Similar Documents

Publication Publication Date Title
MY125356A (en) Moxifloxacin/sodium chloride formulation
DE69839699D1 (en) VAGINAL LACTOBACILLUS MEDICAMENT
AR021074A1 (en) PHARMACEUTICAL COMPOSITION OF MOXIFLOXACINE, PROCEDURE FOR ITS PRODUCTION, AND USE OF SUCH COMPOSITION TO PREPARE AN ANTIBACTERIAL MEDICINAL PRODUCT.
IT1306716B1 (en) ASSOCIATION OF LACTIC BACTERIA AND ITS USE FOR THE PREVENTION AND / OR THERAPEUTIC TREATMENT OF INFECTIONS AND INFLAMMATORY STATES.
AU2003291227A8 (en) Antibacterial agents
WO2001092309A3 (en) Human beta-defensin-3 (hbd-3), a highly cationic beta-defensin antimicrobial peptide
DE60331849D1 (en) ANTIBACTERIAL ACTIVE SUBSTANCES
IT1307850B1 (en) PHARMACEUTICAL COMPOSITION BASED ON LACTIC FERMENTS AND NON-ABSORBABLE CARBOHYDRATIN CONTAINING A CALCIUM SALT AND AN ALUMINUM SALT
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
ATE178798T1 (en) USE BEFORE SIMPLE OR CONJUGATED DEXTRAN IN THE PRODUCTION OF A MEDICATION TO PREVENT OR REDUCE THE RISK OF A BACTERIAL PATHOGENIC INFECTION
WO2001010901A3 (en) Antimicrobial histone h1 compositions, kits, and methods of use thereof
AU6453596A (en) Fungicidal mixtures
BR0309878A (en) Heterotricyclyl-6-alkylidene penenes as beta-lactamase inhibitors
BR0207436A (en) Lactic acid bacteria to prevent infection with intimin expressing pathogens
AU2001281880A1 (en) Use of a formulation made of or containing at least one dissimilated milk serum
AU2251302A (en) Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
WO1999012552A8 (en) 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
DE60033416D1 (en) USE OF HYPOESTOXIDES AS ANTIPARASITIC AGENTS
BR0212143A (en) Mouthwash composition for treating or preventing bacterial or fungal infection
BR0112514A (en) Uses for nad synthetase inhibitors
CA2301872A1 (en) 8a-azalides as veterinary antimicrobial agents
DE69904658D1 (en) Bactericidal compositions active against Ralstonia Solanacearum
WO1999041614A3 (en) Method for detecting intimin producing microorganisms
WO2001045743A3 (en) Use of an enzyme to improve the resorption of medicaments in the tissue
BR0007491A (en) Use of 3-isoxazolidinones and hydroxylamic acids to treat infections

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 4O, 5O, 6O E 7O ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009.